Wild-type SHP2 remains monomeric under physiological conditions, whereas disease-associated mutations (e.g., D61G, E76A, E76K, Y279C, T468L) identified in Noonan syndrome patients confer aberrant LLPS capacity. Here, PTPN11 is linked to Noonan syndrome.